5VM

5AM Venture Management Portfolio holdings

AUM $360M
1-Year Est. Return 345.76%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+345.76%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$360M
AUM Growth
+$42.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
22
New
Increased
Reduced
Closed

Top Buys

1
+$5.82M

Top Sells

1
+$22.9M
2
+$22.7M
3
+$11.9M
4
RLYB icon
Rallybio
RLYB
+$1.11M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ERAS icon
1
Erasca
ERAS
$3.99B
$56.4M 15.66%
3,485,971
-1,919,433
TRDA icon
2
Entrada Therapeutics
TRDA
$274M
$51.2M 14.21%
4,056,379
TYRA icon
3
Tyra Biosciences
TYRA
$1.99B
$39.4M 10.94%
1,029,298
CAMP icon
4
CAMP4 Therapeutics
CAMP
$228M
$25.9M 7.19%
5,869,091
CNTA
5
Centessa Pharmaceuticals
CNTA
$6.15B
$23.1M 6.41%
580,945
PHVS icon
6
Pharvaris
PHVS
$2.11B
$22.5M 6.26%
797,600
MPLT
7
MapLight Therapeutics
MPLT
$1.33B
$19.3M 5.36%
950,011
TECX
8
Tectonic Therapeutic
TECX
$588M
$18.8M 5.21%
606,660
CLDX icon
9
Celldex Therapeutics
CLDX
$2.47B
$15.8M 4.38%
497,270
ARTV
10
Artiva Biotherapeutics
ARTV
$385M
$15.2M 4.21%
2,353,304
EYPT icon
11
EyePoint Inc
EYPT
$1.14B
$13.5M 3.76%
1,050,000
SRZN icon
12
Surrozen
SRZN
$304M
$11.3M 3.13%
387,500
ZNTL icon
13
Zentalis Pharmaceuticals
ZNTL
$285M
$9.24M 2.56%
3,947,913
GHRS icon
14
GH Research
GHRS
$1.65B
$8.05M 2.24%
572,665
TARA icon
15
Protara Therapeutics
TARA
$261M
$7.14M 1.98%
1,369,782
BHVN icon
16
Biohaven
BHVN
$1.66B
$6.25M 1.74%
738,972
ALXO icon
17
ALX Oncology
ALXO
$256M
$6.13M 1.7%
+3,057,325
SKYE icon
18
Skye Bioscience
SKYE
$27.3M
$5.95M 1.65%
9,681,763
RLYB icon
19
Rallybio
RLYB
$76.6M
$2.62M 0.73%
291,788
-162,053
SLN
20
Silence Therapeutics
SLN
$326M
$2.51M 0.7%
476,200
ELVN icon
21
Enliven Therapeutics
ELVN
$2.41B
– –
-772,477
VRDN icon
22
Viridian Therapeutics
VRDN
$1.95B
– –
-736,595